InDaily InDaily

Support independent Journalism Donate Subscribe
Support independent journalism


ACCC appeals to raise fine against Nurofen


The consumer watchdog is appealing what it says is an inadequate fine imposed by the Federal Court against the makers of Nurofen over misplaced claims of targeted pain relief.

1 Comment
1 Comment Print article

The Australian Competition and Consumer Commission says Reckitt Benckiser should have been fined at least $6 million, rather than the $1.7 million imposed, because the company made millions from products it misleadingly claimed were tailored to treat specific pain.

“The ACCC will submit to the Full Court of the Federal Court that $1.7 million in penalties imposed on a company the size of Reckitt Benckiser does not act as an adequate deterrent and might be viewed as simply a cost of doing business,” ACCC chairman Rod Sims said in a statement today.


Make a comment View comment guidelines

Local News Matters

Media diversity is under threat in Australia – nowhere more so than in South Australia. The state needs more than one voice to guide it forward and you can help with a donation of any size to InDaily. Your contribution goes directly to helping our journalists uncover the facts. Please click below to help InDaily continue to uncover the facts.

Donate today
Powered by PressPatron


1 Show comments Hide comments
Will my comment be published? Read the guidelines.

More News stories

Loading next article